Compass Therapeutics, Inc.
NASDAQ:CMPX
2.58 (USD) • At close July 1, 2025
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
| Omzet
| 0.85 | 0 | 0 | 0 | 0 | 0 | 0 |
| Kosten van de omzet
| 0 | 1.89 | 1.904 | 1.624 | 2.404 | 2.12 | 1.921 |
| Brutowinst
| 0.85 | -1.89 | -1.904 | -1.624 | -2.404 | -2.12 | -1.921 |
| Brutowinstmarge
| 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Onderzoek- en ontwikkelingskosten
| 42.342 | 37.421 | 29.997 | 20.337 | 14.904 | 22.449 | 27.095 |
| Algemene en administratieve kosten
| 15.133 | 12.243 | 11.658 | 10.927 | 12.908 | 11.603 | 11.217 |
| Verkoop- en marketingkosten
| 0 | 11.04 | 0 | 0 | 0 | 0 | 0 |
| Verkoop-, algemene en administratieve kosten
| 15.133 | 11.052 | 11.658 | 10.927 | 12.908 | 11.603 | 11.217 |
| Overige kosten
| 0 | 0 | 0 | 50.618 | 0 | 0 | 0 |
| Bedrijfskosten
| 57.475 | 48.473 | 41.655 | 31.264 | 27.812 | 34.052 | 38.312 |
| Bedrijfsresultaat
| -56.625 | -50.363 | -41.655 | -81.882 | -27.812 | -34.052 | -38.312 |
| Bedrijfsresultaat ratio
| -66.618 | 0 | 0 | 0 | 0 | 0 | 0 |
| Totaal overige inkomsten en kosten netto
| 7.25 | 7.869 | 2.43 | -0.299 | -1.656 | -0.601 | 0.233 |
| Inkomen voor belasting
| -49.375 | -42.494 | -39.225 | -82.181 | -29.468 | -34.653 | -38.183 |
| Inkomen voor belasting ratio
| -58.088 | 0 | 0 | 0 | 0 | 0 | 0 |
| Belastingkosten
| 0 | 0 | -2.43 | 0.37 | 0.032 | 0.091 | 0.103 |
| Nettowinst
| -49.375 | -42.494 | -36.795 | -82.551 | -29.5 | -34.744 | -38.286 |
| Nettowinstmarge
| -58.088 | 0 | 0 | 0 | 0 | 0 | 0 |
| WPA (Winst Per Aandeel)
| -0.36 | -0.33 | -0.35 | -1.31 | -0.52 | -0.67 | -0.73 |
| Verwaterde WPA
| -0.36 | -0.33 | -0.35 | -1.31 | -0.52 | -0.67 | -0.73 |
| EBITDA
| -54.872 | -48.473 | -37.391 | -29.611 | -25.32 | -31.189 | -35.728 |
| EBITDA ratio
| -64.555 | 0 | 0 | 0 | 0 | 0 | 0 |